2022
DOI: 10.1111/nmo.14317
|View full text |Cite
|
Sign up to set email alerts
|

Effect of phosphodiesterase‐4 inhibitor rolipram on colonic hypermotility in water avoidance stress rat model

Abstract: Background Phosphodiesterase (PDE) inhibition has been reported to play a role in regulating gut motility, but the evidence is insufficient, and the mechanism remains unknown. The aim of this study was to investigate the possible role of phosphodiesterase‐4 (PDE4) inhibitor rolipram in water avoidance stress‐induced colonic hypermotility. Methods A rat model of irritable bowel syndrome (IBS) with diarrhea (IBS‐D) was established by water avoidance stress (WAS). Intestinal motility was assessed by fecal pellets… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 53 publications
0
3
0
Order By: Relevance
“…Previous studies have reported that the PDE4 inhibitors, rolipram and roflumilast, produced a dose-related inhibition of stress-induced increased fecal pellet output in vivo in animals ( Barone et al, 2008 ; Yuan et al, 2022 ). Moreover, high concentrations of rolipram (higher than 10 –5 M) inhibited the spontaneous contraction of colonic smooth muscle strips in vitro , and this inhibitory effect was partly through the cAMP–-PKA-p-CREB pathway and NO pathway ( Yuan et al, 2022 ). In the present study, the PDE4 inhibitor drotaverine did not affect the spontaneous activity of the smooth muscle.…”
Section: Discussionmentioning
confidence: 97%
“…Previous studies have reported that the PDE4 inhibitors, rolipram and roflumilast, produced a dose-related inhibition of stress-induced increased fecal pellet output in vivo in animals ( Barone et al, 2008 ; Yuan et al, 2022 ). Moreover, high concentrations of rolipram (higher than 10 –5 M) inhibited the spontaneous contraction of colonic smooth muscle strips in vitro , and this inhibitory effect was partly through the cAMP–-PKA-p-CREB pathway and NO pathway ( Yuan et al, 2022 ). In the present study, the PDE4 inhibitor drotaverine did not affect the spontaneous activity of the smooth muscle.…”
Section: Discussionmentioning
confidence: 97%
“…The NO is a potent smooth muscle relaxant and relaxes all the smooth muscles in the body [ 6 , 16 - 17 ]. There is ample evidence to suggest the involvement of nitric oxide in regulating intestinal contractility [ 6 , 18 - 19 ]. A recent study claimed that BPA caused a significant inhibition of duodenal movement by involving NO [ 6 ].…”
Section: Discussionmentioning
confidence: 99%
“…PDEs constitute a large family of enzymes that catalyze the degradation of cAMP and/or cGMP, and are important in modulating the intracellular concentrations of the cyclic nucleotides and in controlling their downstream signal transduction, involving cAMP-response element-binding protein (CREB) and NF-κB (Yuan et al, 2022;Chinn et al, 2022). PDE4B has attracted more attention because of its close relationship with inflammatory disease (Amata et al, 2014).…”
Section: Discussionmentioning
confidence: 99%